学术探索
学术期刊
新闻热点
数据分析
智能评审

Hyperlipidemia in solid organ transplantation

被引：253
作者：
Kobashigawa, JA
Kasiske, BL
机构：
[1] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90095 USA
[2] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
[3] HENNEPIN CTY MED CTR, MINNEAPOLIS, MN USA
来源：
TRANSPLANTATION | 1997年 / 63卷 / 03期
关键词：
D O I：
10.1097/00007890-199702150-00001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：331 / 338
页数：8
相关论文
共 86 条
[1]  
APANAY DC, 1994, TRANSPLANTATION, V58, P663
[2]   LIPOPROTEIN LEVELS AND POSTHEPARIN LIPASE ACTIVITIES IN KIDNEY-TRANSPLANT RECIPIENTS - CYCLOSPORINE VS NON-CYCLOSPORINE-TREATED PATIENTS [J].
ARNADOTTIR, M ;
THYSELL, H ;
NILSSONEHLE, P .
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (05) :391-396
[3]   PLASMA-CONCENTRATION PROFILES OF SIMVASTATIN 3-HYDROXY-3-METHYL-GLUTARYL-COENZYME-A REDUCTASE INHIBITORY ACTIVITY IN KIDNEY-TRANSPLANT RECIPIENTS WITH AND WITHOUT CYCLOSPORINE [J].
ARNADOTTIR, M ;
ERIKSSON, LO ;
THYSELL, H ;
KARKAS, JD .
NEPHRON, 1993, 65 (03) :410-413
[4]   FOLLOW-UP OF LIPID AND APOPROTEIN LEVELS IN RENAL-TRANSPLANT RECIPIENTS [J].
AVERNA, MR ;
BARBAGALLO, CM ;
SPARACINO, V ;
CAPUTO, F ;
MANCINO, C ;
CALABRESE, S ;
NOTARBARTOLO, A .
NEPHRON, 1991, 58 (02) :255-256
[5]   CYCLOSPORINE-A HAS DIVERGENT EFFECTS ON PLASMA LDL CHOLESTEROL (LDL-C) AND LIPOPROTEIN(A) [LP(A)] LEVELS IN RENAL-TRANSPLANT RECIPIENTS - EVIDENCE FOR RENAL INVOLVEMENT IN THE MAINTENANCE OF LDL-C AND THE ELEVATION OF LP(A) CONCENTRATIONS IN HEMODIALYSIS-PATIENTS [J].
AZROLAN, N ;
BROWN, CD ;
THOMAS, L ;
HAYEK, T ;
ZHAO, ZH ;
ROBERTS, KG ;
SCHEINER, C ;
FRIEDMAN, EA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (09) :1393-1398
[6]   HYPERLIPIDEMIA AFTER HEART-TRANSPLANTATION - REPORT OF A 6-YEAR EXPERIENCE, WITH TREATMENT RECOMMENDATIONS [J].
BALLANTYNE, CM ;
RADOVANCEVIC, B ;
FARMER, JA ;
FRAZIER, OH ;
CHANDLER, L ;
PAYTONROSS, C ;
COCANOUGHER, B ;
JONES, PH ;
YOUNG, JB ;
GOTTO, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) :1315-1321
[7]   LOW-DOSE SIMVASTATIN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RECIPIENTS OF CARDIAC TRANSPLANTATION [J].
BARBIR, M ;
ROSE, M ;
KUSHWAHA, S ;
AKL, S ;
MITCHELL, A ;
YACOUB, M .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1991, 33 (02) :241-246
[8]  
BECKER DM, 1988, AM J MED, V85, P632
[9]   THE LONG-TERM EFFECTS OF THE LIPID-LOWERING AGENT FENOFIBRATE IN HYPERLIPIDEMIC HEART-TRANSPLANT RECIPIENTS [J].
BOISSONNAT, P ;
SALEN, P ;
GUIDOLLET, J ;
FERRERA, R ;
DUREAU, G ;
NINET, J ;
RENAUD, S ;
DELORGERIL, M .
TRANSPLANTATION, 1994, 58 (02) :245-247
[10]  
BROWN JH, 1993, NEPHROL DIAL TRANSPL, V8, P863
123456789